MedPath
TGA Approval

SPEDRA avanafil 200 mg tablet blister pack (228476)

228476

SPEDRA avanafil 200 mg tablet blister pack

A Menarini Australia Pty Ltd

April 6, 2016

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/55cf60f52c374b93c2722d565967bb88.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/b9caf7121194a21d0b372e91c216d498.pdf

Active Ingredients

avanafil

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SPEDRA avanafil 200 mg tablet blister pack (228476) - TGA 批准文号 | MedPath